Skip to main content
Log in

Evaluation of Anti-Hyperglycemic Effect of Synthetic Schiff Base Vanadium(IV) Complexes

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

A chain of new vanadium(IV) complexes of Schiff bases, derived from acetohydrazide (HL1-3) or 4-aminoantipyrine (HL4-7) have been prepared and physicochemically distinguished using different tools including analytical, spectral, and magnetic techniques. The spectral and analytical data showed that ligands HL1-3 acted as neutral bidentate ligands, chelated through hydrazono carbonyl and azomethine groups, whereas HL4 acted as neutral tetradentate ligand coordinated via pyrazolone carbonyl, NH group, hydrazono carbonyl, and azo (N=N) groups forming binuclear complexes. The HL5 and HL6 behave as neutral bidentate ligands coordinating through pyrazolone carbonyl and NH groups; in case of ligand HL6, in addition to the mentioned mode, C=N and CN groups participated to bind a second VO(II) ion form binuclear complexes. HL7 behaves as a monobasic bidentate ligand bonded via deprotonated OH and azomethine groups. All complexes adopt square pyramidal geometry around vanadium ion. Results revealed that the oral management of vanadium complexes significantly reduced the blood glucose level in rats suffered from diabetes. The correction of altered biochemical parameters via treatment with vanadium complexes points the improved glucose balance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.
Fig. 6.

Similar content being viewed by others

References

  1. V. Sabetsky and J. Ekblom, Pharmacol. Res., 61, 1 – 4 (2010).

    Article  CAS  PubMed  Google Scholar 

  2. American Diabetes Association: Diagnosis and Classification of Diabetes Mellitus, Diabetes Care., 33, S62 – S69 (2010).

    Article  Google Scholar 

  3. Diabetes Mellitus: Reports of a WHO Study Group, WHO Technical Report Series, 727, 876 (1985).

  4. B. Ramachandran, D. S. Sekar,M. Kandaswamy, et al., Exp. Diabetes Res, 5, 137 – 142 (2004).

    Article  CAS  Google Scholar 

  5. B. Ramachandran, M. Kandaswamy, V. Narayanan, and S. Subramanian, Diabetes Obes. Metab., 5, 455 – 461 (2003).

    Article  CAS  PubMed  Google Scholar 

  6. B. Ramachandran, K. Ravi, V. Narayanan, et al., Clin. Chim. Acta, 345, 141 – 150 (2004).

    Article  CAS  PubMed  Google Scholar 

  7. B. Ramachandran, K. Ravi, V. Narayanan, et al., Chem. Biol. Interact, 149, 9 – 21 (2004).

    Article  CAS  PubMed  Google Scholar 

  8. H. K. Thompson and C. Orvig, J. Chem. Soc. Dalton Trans., 2885 – 2892 (2000).

  9. H. Sakurai, H. Sano, T. Takino, and H. Yasui, J. Inorg. Biochem., 80, 99 – 105 (2000).

    Article  CAS  PubMed  Google Scholar 

  10. C. E. Heyliger, A. G. Tahiliani, and J. H. Mcneill, Science, 227, 1474 – 1477 (1985).

    Article  CAS  PubMed  Google Scholar 

  11. H. Degani, M. Gochin, S. J. D. Karlish, and Y. Shechter, Biochem., 20, 5795 – 5799 (1981).

    Article  CAS  Google Scholar 

  12. Experimental Models of Diabetes, J. H. McNeill (Ed.), CRC Press, Boca Raton (1999).

  13. A. S. El-Tabl, F. A. El-Saied, W. Plass, and A. N. Al-Hakimi, Spectrochim Acta Part A, 71, 90 – 99 (2008).

    Article  Google Scholar 

  14. F. A. El-Saied, M. M. E. Shakdofa, and A. N. Al-Hakimi, J. Korean Chem. Soc., 55, 444 – 453 (2011).

    Article  CAS  Google Scholar 

  15. S. M. Emam, F. A. El-Saied, S. A. Abou El-Enein, and H. A. El-Shater, Spectrochim. Acta Part A, 72, 291 – 297 (2009).

    Article  Google Scholar 

  16. F. A. El-Saied, M. I. Ayad, R. M. Issa, and S. A. Aly. Polish J. Chem., 75, 773 – 783 (2001).

    CAS  Google Scholar 

  17. F. A. El-Saied, M. I. Ayad, R. M. Issa, and S. A. Aly, Polish J. Chem., 74, 919 – 926 (2000).

    CAS  Google Scholar 

  18. L. Lewis and R. G. Wilkins, Modern Coordination Chemistry, Interscience, New York (1960).

    Google Scholar 

  19. N. Rakieten, M. L. Rakieten, and M. V. Nadkarni, Cancer Chemother. Rep., 29, 91 – 98 (1963).

    Google Scholar 

  20. L. J. Fischer and D. E.Rickert, CRC Crit. Rev. Toxicol., 3, 231 – 263 (1975).

    Article  CAS  PubMed  Google Scholar 

  21. J. H. Roe and R. E. Dailey, Anal. Biochem., 15, 245 – 250 (1966).

    Article  CAS  PubMed  Google Scholar 

  22. E. Beutler, O. Duron, and M. B. Kelly, J. Lab. Clin. Med., 61, 882 – 888 (1963).

    CAS  PubMed  Google Scholar 

  23. H. Ohkawa, A.Wakatsuki, and C. Kaneada, Anal. Biochem., 95, 351 – 358 (1982).

    Article  Google Scholar 

  24. S. C. Jamdar and O. Greengard. J. Biol. Chem., 245, 2779 – 2783 (1970).

    CAS  PubMed  Google Scholar 

  25. N. N. Greenwood, B. P. Straughan, and A. E. Wilson, J. Chem. Soc. A, 2209 – 2212 (1968).

  26. M. H. Hamada, O. El-Shafai, and A. A. El-Asmy, Trans. Met. Chem., 31, 714 – 719 (2006).

    Article  CAS  Google Scholar 

  27. A. A. El-Asmy, I. M. Gaber, N. M. El-Metwally, et al., J. Coord. Chem., 61, 3620 – 3633 (2008).

    Article  CAS  Google Scholar 

  28. T. H. Rakha and M. M. Bekheit, Chem. Pharm. Bull., 48, 914 – 919 (2000).

    Article  CAS  PubMed  Google Scholar 

  29. S. I. Pillai, S. P. Subramanian, and M. Kandaswamy, Eur. J. Med. Chem C., 63 , 109 – 117 (2013).

    Article  CAS  Google Scholar 

  30. M. van den Brand, L. D. Elving, J. P. Drenth, and J. H. van Krieken, Neth. J. Med., 67, 394 – 396 (2009).

    PubMed  Google Scholar 

  31. N. Moller and K. S. Nair, Diabetes, 57, 3 – 4 (2008).

    Article  PubMed  Google Scholar 

  32. P. H. Sugden and S. J. Fuller, Biochem. J., 273, 21 – 37 (1991).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. H. Braunlich, F. Marx, C. Fleck, and G. Stein, Exp. Toxicol. Pathol., 49, 135 – 139 (1997).

    Article  CAS  PubMed  Google Scholar 

  34. M. G. Bischof, M. Krssak, M. Krebs, et al., Diabetes, 50, 392 – 398 (2001).

    Article  CAS  PubMed  Google Scholar 

  35. M. Laakso, M. Malkki, and S. Deeb, Diabetes, 44, 330 – 334 (1995).

    Article  CAS  PubMed  Google Scholar 

  36. R. M. O’Doherty, D. L. Lehman, S. Telemaque-Potts, and C. B. Newgard, Diabetes, 48, 2022 – 2027 (1999).

    Article  PubMed  Google Scholar 

  37. D. Gupta, J. Raju, J. Prakash, and N. Z. Baquer, Diabetes. Res. Clin. Pract., 46, 1?7 (1999).

    Article  CAS  PubMed  Google Scholar 

  38. P. Malini, G. Kanchana, and M. Rajadurai, Asian J. Pharmaceut. Clin. Res., 4 (3), 124 – 128 (2011).

    Google Scholar 

  39. M. Krooeniak, M. Gawlik, and R. Grybooe, Bull. Vet. Inst. Pulawy, 53, 535 – 540 (2009).

    Google Scholar 

  40. T. Yilmaz-Ozden, O. Kurt-Sirin, S. Tunali, et al., Bosn. J. Basic. Med. Sci., 14(2), 105 – 109 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

The authors are thankful to the Scientific Research Deanship, Qassim University, KSA, for financially supporting research project number 1201 (2012).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. M. E. Shakdofa.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

El-Saied, F.A., Salem, T.A., Aly, S.A. et al. Evaluation of Anti-Hyperglycemic Effect of Synthetic Schiff Base Vanadium(IV) Complexes. Pharm Chem J 51, 833–842 (2017). https://doi.org/10.1007/s11094-017-1702-4

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-017-1702-4

Key words

Navigation